As with any aspect of your treatment, your healthcare provider can offer personalized guidance based on your health history and individual needs
Part D plans participating in the model are required to place all model drugs on the same formulary tier, cover all medically accepted indications for model drugs, and apply the same cost sharing to all indications
This requires doctors to continuously update their knowledge about new treatments, side effects, and best practices
Other possibilities include diverticular disease, inflammatory bowel disease, colorectal polyps or cancer, and medication-related bleeding from concurrent use of anticoagulants, antiplatelet agents, or NSAIDs
The most common reports are mild redness at the injection site, occasional small bumps that resolve on their own, and sometimes a few days of fatigue at the start as AMPK activation ramps up